Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results

Objectives Recently, the results of two economic evaluations were published both of which seemingly demonstrate the cost-effectiveness of sofosbuvir-based regimens for the treatment of chronic hepatitis C genotype 1 infection in Germany. Both analyses were sponsored by the manufacturer of sofosbuvir...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2020-10, Vol.15 (10), p.e0236543
1. Verfasser:	Gandjour, Afschin
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral drugs Biology and Life Sciences Chronic infection Clinical outcomes Committees Cost analysis Cost benefit analysis Cost control Dosage and administration Drug therapy Economic aspects Economic models Efficiency Engineering and Technology Evaluation Genotype & phenotype Genotypes Health care Hepatitis Hepatitis C Infections Intervention Life expectancy Medicine and Health Sciences Methods Patients People and Places Prices RNA polymerase Social Sciences Sofosbuvir Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!